BNO 5.26% 20.0¢ bionomics limited

BNO - Good Profits Ahead, page-22

  1. 590 Posts.
    lightbulb Created with Sketch. 4
    Who knows what DR has planned for the next 5 weeks in the lead up the the AGM. But if she is worth anything as CEO she should be out in her nicest suit doing everything in her power to get a partnership.

    If she can't get a partnership her days as ceo are clearly numbered. The next ceo will be tasked with partnering or selling everything.

    I honestly don't think it will come to cap raise - anyone who has been in bno for any amount of time knows that she & the board were so close to going after raising in America.

    My predictions:

    * agitation study comes out late, in April
    * DR might get a partnership (I don't think she will)
    * 2 new drugs are going to be put up as the way forward - DR does not have enough time for this strategy
    * If DR can't get a partnership she will be gone after June 2019
    * If there is a new CEO there will be no BNO in 2022
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.